# Establishes a wound care kit and xylazine test strip distribution

**Bill ID:** S9728
**Session:** 2024
**Sponsor:** Nathalia Fernandez
**Status:** In Senate Committee
**PDF:** [S9728 PDF](https://legislation.nysenate.gov/pdf/bills/2024/S9728)

## Summary

Establishes a wound care kit and xylazine test strip distribution program to supply wound care kits designed for the treatment of injection-related wounds and skin and soft tissue infections, and xylazine test strips, to individuals with a substance use disorder or who are otherwise at risk of drug use, free of charge; prohibits facilities from collecting personally identifying information on such individuals; prohibits police from targeting individuals receiving wound care kits or xylazine test strips under such program.

---

## Full Text

S T A T E  O F  N E W  Y O R K
 ________________________________________________________________________
 
  9728
 
  I N  S E N A T E
 
  May 23, 2024
  ___________
 
 Introduced by Sen. FERNANDEZ -- read twice and ordered printed, and when
  printed  to  be committed to the Committee on Alcoholism and Substance
  Use Disorders
 
 AN ACT to amend the mental hygiene law, in relation  to  establishing  a
  wound care kit and xylazine test strip distribution program
 
  THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
  Section 1. The mental hygiene law is amended by adding a  new  section
 19.47 to read as follows:
 ยง 19.47 WOUND CARE KIT AND XYLAZINE TEST STRIP DISTRIBUTION PROGRAM.
  1. THE COMMISSIONER SHALL ESTABLISH A PROGRAM WHEREBY INDIVIDUALS WITH
 A  SUBSTANCE  USE  DISORDER OR WHO ARE OTHERWISE AT RISK OF DRUG USE MAY
 RECEIVE, FREE OF CHARGE, WOUND CARE KITS SPECIFICALLY DESIGNED  FOR  THE
 TREATMENT  OF  INJECTION-RELATED  WOUNDS  AND  SKIN  AND  SOFT  TISSUE
 INFECTIONS, AND XYLAZINE TEST STRIPS TO DETECT THE PRESENCE OF XYLAZINE.
 THE FOLLOWING FACILITIES MAY APPLY TO DISTRIBUTE SUCH  WOUND  CARE  KITS
 AND XYLAZINE TEST STRIPS:
  (A) HOSPITAL EMERGENCY ROOMS;
  (B) ADDICTION TREATMENT FACILITIES;
  (C) FACILITIES FOR SUBSTANCE USE DISORDER PROGRAMS;
  (D) HOMELESS SHELTERS;
  (E) URGENT CARE CENTERS;
  (F) MOBILE HEALTH UNITS;
  (G) PUBLIC HEALTH OFFICES;
  (H) SAFE SYRINGE PROGRAMS; AND
  (I)  ANY  OTHER  SETTING,  AS  DETERMINED  BY THE DEPARTMENT, WHICH IS
 ROUTINELY ACCESSED BY INDIVIDUALS WITH A SUBSTANCE USE DISORDER  OR  WHO
 ARE  OTHERWISE AT RISK OF DRUG USE, AND WHO ARE IN NEED OF TREATMENT FOR
 INJECTION-RELATED WOUNDS AND SKIN AND SOFT  TISSUE  INFECTIONS,  OR  WHO
 WOULD BENEFIT FROM THE USE OF XYLAZINE TEST STRIPS.
  2.  FACILITIES DISTRIBUTING WOUND CARE KITS AND XYLAZINE TEST STRIPS
 PURSUANT TO SUBDIVISION  ONE  OF  THIS  SECTION  SHALL  NOT  RECORD  ANY
 PERSONALLY  IDENTIFYING  INFORMATION  REGARDING  TO WHOM SUCH WOUND CARE
 KITS AND XYLAZINE TEST STRIPS ARE DISTRIBUTED.
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
  [ ] is old law to be omitted.
  LBD15370-03-4
 S. 9728  2
 
  3. THE COMMISSIONER, IN COOPERATION WITH THE COMMISSIONER  OF  HEALTH,
 SHALL DEVELOP AND CONDUCT A PUBLIC AWARENESS AND EDUCATIONAL CAMPAIGN ON
 THE  IMPORTANCE  OF  PROPER  WOUND  CARE AND TESTING FOR THE PRESENCE OF
 XYLAZINE FOR INDIVIDUALS WITH A SUBSTANCE USE DISORDER OR WHO ARE OTHER-
 WISE AT RISK OF DRUG USE. SUCH CAMPAIGN SHALL DETAIL HOW TO PROPERLY USE
 THE ITEMS IN WOUND CARE KITS DESIGNED FOR THE TREATMENT OF INJECTION-RE-
 LATED  WOUNDS  AND  SKIN AND SOFT TISSUE INFECTIONS, HOW TO PROPERLY USE
 XYLAZINE TEST STRIPS, AND THE AVAILABILITY OF FREE WOUND CARE  KITS  AND
 XYLAZINE  TEST STRIPS MADE AVAILABLE PURSUANT TO SUBDIVISION ONE OF THIS
 SECTION.
  4. THE PROVISIONS OF THIS SECTION SHALL NOT REPLACE THE  DUTY  OF  ANY
 FACILITY  LISTED  UNDER SUBDIVISION ONE OF THIS SECTION TO PROVIDE ACUTE
 WOUND CARE THAT WOULD OTHERWISE BE PROVIDED BY SUCH FACILITY.
  5. (A) NO POLICE OFFICER AS DEFINED BY SECTION 1.20  OF  THE  CRIMINAL
 PROCEDURE  LAW, PEACE OFFICER AS DEFINED BY SECTION 2.10 OF THE CRIMINAL
 PROCEDURE LAW, OR POLICE AGENCY AS  DEFINED  BY  SECTION  EIGHT  HUNDRED
 THIRTY-FIVE  OF  THE  EXECUTIVE  LAW,  SHALL SUBJECT ANY FACILITY LISTED
 UNDER SUBDIVISION ONE OF THIS SECTION, OR ANY  INDIVIDUAL,  TO  SURVEIL-
 LANCE, INVESTIGATION, OR PROSECUTION FOR DISTRIBUTING OR RECEIVING WOUND
 CARE KITS OR XYLAZINE TEST STRIPS PURSUANT TO THIS SECTION.
  (B)  RECEIPT  OR  POSSESSION  BY  AN INDIVIDUAL OF A WOUND CARE KIT OR
 XYLAZINE TEST STRIP UNDER THE PROGRAM ESTABLISHED PURSUANT  TO  SUBDIVI-
 SION  ONE  OF  THIS  SECTION  SHALL  NOT  CONSTITUTE REASONABLE CAUSE TO
 BELIEVE THAT SUCH INDIVIDUAL HAS COMMITTED AN OFFENSE  OR  CRIME  SUFFI-
 CIENT TO AUTHORIZE ARREST UNDER SECTION 140.10 OF THE CRIMINAL PROCEDURE
 LAW,  AND  SHALL NOT BE THE BASIS OF ANY SEARCH OR SEIZURE OF SUCH INDI-
 VIDUAL OR SUCH INDIVIDUAL'S PROPERTY.
  ยง 2. This act shall take effect on the one hundred eightieth day after
 it shall have become a law. Effective immediately, the addition,  amend-
 ment and/or repeal of any rule or regulation necessary for the implemen-
 tation  of  this act on its effective date are authorized to be made and
 completed on or before such effective date.